Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CBLI

Cleveland BioLabs (CBLI) Stock Price, News & Analysis

Cleveland BioLabs logo

About Cleveland BioLabs Stock (NASDAQ:CBLI)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
$2.20
$4.34
52-Week Range
N/A
Volume
13,770 shs
Average Volume
271,922 shs
Market Capitalization
$5,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cytocom, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule immunotherapies. Its product applies to autoimmune, inflammatory, infectious diseases and cancers. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Fort Collins, CO.

Remove Ads
Receive CBLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cleveland BioLabs and its competitors with MarketBeat's FREE daily newsletter.

CBLI Stock News Headlines

Cleveland Construction News
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
Best Hospitals in Cleveland, OH
Cleveland Clinic Rehabilitation Hospital
Getting Around Cleveland
See More Headlines

CBLI Stock Analysis - Frequently Asked Questions

Cleveland BioLabs, Inc. (NASDAQ:CBLI) released its earnings results on Friday, May, 15th. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $0.16 million for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cleveland BioLabs investors own include iBio (IBIO), Inovio Pharmaceuticals (INO), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Dynavax Technologies (DVAX), Novavax (NVAX) and BioCryst Pharmaceuticals (BCRX).

Company Calendar

Last Earnings
5/15/2020
Today
4/07/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CBLI
Fax
N/A
Employees
4
Year Founded
2003

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-2,400,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$260,000.00
Price / Cash Flow
N/A
Book Value
$0.87 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$5,000.00
Optionable
Not Optionable
Beta
0.70

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:CBLI) was last updated on 4/7/2025 by MarketBeat.com Staff
From Our Partners